Xiaoxi Huang

机构：Haikou City People's Hospital, Hainan Medical University · ORCID：0000-0002-1548-2335

发表论文 133 篇 · 总被引 1990 次 · h-index 26

代表论文

• Healthy lifestyles, systemic inflammation and breast cancer risk: a mediation analysis (2024 · BMC Cancer · 被引 34)
• Efficacy and safety of tocilizumab in patients with refractory generalized myasthenia gravis (2024 · CNS Neuroscience & Therapeutics · 被引 21)
• Tetrandrine Alleviates Silica-induced Pulmonary Fibrosis Through PI3K/AKT Pathway: Network Pharmacology Investigation and Experimental Validation (2024 · Inflammation · 被引 19)
• VPS9D1-AS1 antisense therapy via lipid nanoparticles reprograms cold tumors and enhances immunotherapy in colorectal cancer (2025 · Journal of Controlled Release · 被引 14)
• Hematological and biochemical markers influencing breast cancer risk and mortality: Prospective cohort study in the UK Biobank by multi-state models (2023 · The Breast · 被引 11)
• Efficacy and safety of efgartigimod versus intravenous immunoglobulin in early intervention of acetylcholine receptor antibody-positive impending myasthenic crisis: A retrospective cohort study (2025 · Neurotherapeutics · 被引 10)